mardi 26 janvier 2021

AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon™

Par Rédaction , dans Communiqués , le 21 avril 2016

Thursday, April 21st 2016 at 4:30pm UTC

TEL AVIV, Israel–(BUSINESS WIRE)– AV Medical Technologies Ltd. announced today the culmination of a 30
patient study that evaluated the proprietary design of the Chameleon™
angioplasty balloon catheter. The study was conducted by Dr. Anthony
Verstandig, Director of Interventional Radiology at Shaare Zedek Medical
Center in Jerusalem. Study results were presented during an oral
abstract presentation at the recent Society of Interventional Radiology
(SIR) conference held in Vancouver, Canada.

Discussing his Initial Clinical Experience with the Chameleon™ at SIR,
Dr. Verstandig stated, “The Chameleon™ demonstrated clear advantages
compared to standard balloon designs. Among these are reduced catheter
exchanges and maintaining guidewire access during contrast injection
through the catheter. In addition, the Chameleon™ design allows hands
free reflux angiography, simplifying visualization of the entire AV
graft circuit.”

Mrs. Limor Sandach, AV Medical’s CEO, commented, “We are very pleased
with the results of this trial and we are excited to commence our US
launch. The Chameleon™ balloon offers unique advantages over standard
balloon catheters. We are confident that physicians will appreciate the
benefits provided by our proprietary SuperVision™ feature.”

SuperVision™ is a proximal injection technology enabling simultaneous
catheter based interventions and contrast fluid injection for imaging in
one device, eliminating multiple exchanges and maintaining guidewire
access. This proprietary technology enhances performance by achieving
superior targeted imaging and a smoother and more efficient procedure.

About A-V Medical

AV Medical Technologies Ltd, a privately held medical device company
headquartered in Israel, is dedicated to the development of advanced and
efficient solutions in catheter-based interventions. The company is now
focusing on its flagship catheter, the Chameleon™, targeted for dialysis
patients undergoing routine angioplasty procedures. The company was
founded by Dr. Michael Tal, interventional radiologist and serial


AV Medical Technologies Ltd.
John Rappe, 703-407-3980
Business Officer

Source: AV Medical Technologies Ltd.

Étiquettes : , , , , , , , , , , , , , , ,